Amicus Therapeutics
FOLD
#3908
Rank
S$3.95 B
Marketcap
S$12.83
Share price
-0.50%
Change (1 day)
-1.80%
Change (1 year)

Amicus Therapeutics (FOLD) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.57 Billion

According to Amicus Therapeutics 's latest financial reports the company's total debt is S$0.57 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Amicus Therapeutics - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.60 B2.59%
2023-12-31S$0.58 B-3.02%
2022-12-31S$0.60 B1.87%
2021-12-31S$0.59 B1.82%
2020-12-31S$0.58 B106.19%
2019-12-31S$0.28 B-35.52%
2018-12-31S$0.43 B100.18%
2017-12-31S$0.21 B-1.96%
2016-12-31S$0.22 B280.6%
2015-12-31S$58.84 M210.35%
2014-12-31S$18.96 M3.4%
2013-12-31S$18.33 M2051.32%
2012-12-31S$0.85 M-36.96%
2011-12-31S$1.35 M-55.09%
2010-12-31S$3.01 M-45.05%
2009-12-31S$5.47 M220.81%
2008-12-31S$1.7 M-56.39%
2007-12-31S$3.91 M-28.33%
2006-12-31S$5.46 M223.72%
2005-12-31S$1.68 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
S$8.54 B 1,388.21%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.78 B 36.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.39 B-30.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$30.92 B 5,288.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
S$75.35 M-86.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$20.62 B 3,494.07%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark